	Human stem cells for decompensated cirrhosis in adults. Cochrane Database Syst Rev Aung HH, Naing C, Ni H, Aye SN, Htet NH, Kew ST, Pavlov CS. PMID: 41312789 [PubMed - indexed for MEDLINE]
	Altered sphingolipid profile in primary biliary cholangitis: associations with fibrosis and inflammation. Sci Rep Rogalska M, B, Zabielski P, Janica J, Roszczyc-Owsiejczuk K, Pogodzi, Andrzejuk A, D, Flisiak R, Rogalski P. PMID: 41309781 [PubMed - indexed for MEDLINE]
	Global Prevalence, Temporal Trends, and Associated Mortality of Bacterial Infections in Patients with Liver Cirrhosis: A Meta-analysis. J Clin Transl Hepatol Tian YX, Wu BY, An Q, Wu YP, Zuo J, Yeo YH, Fan YC. PMID: 41306366 [PubMed]
	Hepatitis E Virus (HEV) Seroprevalence in Cryptogenic Cirrhosis: From Evidence of High Frequency to the Impact on Disease Progression. Medicina (Kaunas) Yara, Özdo, Tezcan Ülger S, Aslan G, Tiftik EN, Sezgin O. PMID: 41303850 [PubMed - indexed for MEDLINE]
	The Kidney in the Shadow of Cirrhosis: A Critical Review of Renal Failure. Biomedicines Popa LM, Anderco P, Stoia O, Ichim C, Porr C. PMID: 41301868 [PubMed]
	Differential Metabolic Dysregulations in Hepatocellular Carcinoma and Cirrhosis: Insights into Lipidomic Signatures. Biomolecules Ursu CP, Furcea LE, Procope, Ciocan RA, Ursu , Gherman CD, V, Pop RS, Moi, , Socaciu C, Al Hajjar N, Graur F. PMID: 41301494 [PubMed - indexed for MEDLINE]
	Systematic Literature Review and Meta-analysis of the Cardiovascular Effects of Transjugular Intrahepatic Portosystemic Shunt Creation for Decompensated Liver Cirrhosis. J Vasc Interv Radiol Badar W, Khabbaz RC, Ekowa A, Shalaby S, Baiges A, García-Pagán JC, Gaba RC. PMID: 41297588 [PubMed - as supplied by publisher]
	Oxidative Stress and Cirrhosis Severity: A Retrospective Cohort Analysis of Predictive and Interactive Effects with Inflammation. Metabolites P, Boldeanu L, Pîr, Dop D, Cioboat, Bobîrc, R. PMID: 41295297 [PubMed]
	Ferroptosis in liver fibrosis and its potential intervention strategy. Cell Biol Toxicol Zhu W, Fu L, Cui Y, Tang Y, Liu K, Shi L, Gao Y, Li M, Huang L. PMID: 41286189 [PubMed - indexed for MEDLINE]
	"Effectiveness of Oral Nutritional Therapy in Cirrhosis: A Systematic Review and Meta-Analysis of Clinical and Functional Outcomes". Clin Nutr ESPEN Ahmed HM, Ubaid-Ur-Rehman, Owais M. PMID: 41285365 [PubMed - as supplied by publisher]
	MAFLD in Egyptian non-dialysis CKD Patients: Frequency, fibrosis severity, and risk factors. PLoS One Saad ZM, Keryakos HKH, Hassanin HA, Higazi MM, Sayed MM, Ismail DE, Abdelhalim SM. PMID: 41284717 [PubMed - indexed for MEDLINE]
	A Pilot Study of Ascitic Fluid Proteomics in Cirrhosis With Spontaneous Bacterial Peritonitis. J Clin Exp Hepatol Nadda R, Garg P, Duseja A, Verma N. PMID: 41281577 [PubMed]
	Effect of amino acid-balanced diet-based nutritional-psychological intervention on muscle wasting and quality of life in cirrhosis patients. World J Psychiatry Zhuge WW, Zheng LX, Xu LJ, Zhou SF, Yao HX. PMID: 41281509 [PubMed]
	Serum type III procollagen, procollagen V, tumour necrosis factor-a, interleukin-6 in liver cirrhosis after antiviral treatment. J Med Biochem Li W, Liu X, Bi F. PMID: 41281287 [PubMed]
	Factors influencing and enhancing health-related quality of life in sarcopenia patients with liver cirrhosis: A comprehensive review. J Family Med Prim Care Bhagchandani D, Yadav A, Lamba M, Yadav N, Atam V, Yadav P. PMID: 41280583 [PubMed]
	Gut microbiome and its metabolites in liver cirrhosis: mechanisms and clinical implications. Front Cell Infect Microbiol Chang L, Liu Y, Li H, Yan J, Wu W, Chen N, Ma C, Zhao X, Chen J, Zhang J. PMID: 41278477 [PubMed - indexed for MEDLINE]
	Hepatoprotective effects of silybin in liver fibrosis. World J Gastroenterol Liu XX, Hassan W, Ahmed H, Song SZ. PMID: 41278156 [PubMed - indexed for MEDLINE]
	Risk factors, clinical outcomes, and the development of a pragmatic zinc deficiency screening tool in patients with cirrhosis: a prospective cohort study. Eur J Clin Nutr Lakananurak N, Chanwigoon P, Hathayamat W. PMID: 41276701 [PubMed - as supplied by publisher]
	Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio Combined with Model for End-Stage Liver Disease 3.0 as a Prognostic Predictor for Patients with Liver Cirrhosis after Transjugular Intrahepatic Portosystemic Shunt Creation. J Vasc Interv Radiol Suzuki T, Michimoto K, Yamada K, Farsad K. PMID: 41276112 [PubMed - as supplied by publisher]
	Relevance of the Diagnostic Criteria for Diastolic Dysfunction in Patients With Transjugular Intrahepatic Portosystemic Shunt. Liver Int Motto E, Becchetti C, Perricone G, Viganò R, Trevano FALQ, Bolis F, Marcello V, De Nicola S, Morelli F, Andriulo C, Phillips A, Furci C, Musca F, De Marco P, Conti S, Solcia M, Belli LS, Airoldi A. PMID: 41272921 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 37483

Page 1 of 1875



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy